Centrum Systemów Bio-Medycznych sp. z o. o.

What Centrum Systemów Bio-Medycznych sp. z o. o. does

Centrum Systemów Bio-Medycznych sp. z o. o. (CSB) is a Polish medical-software company founded in 2019, headquartered in Głogów Małopolski (Podkarpackie region), and operating across Central Europe (Poland, Czech Republic, Slovakia). It develops TYRION, an AI-powered clinical decision-support system that analyzes intraoperative X-ray and 3D tomosynthesis images of breast tissue to identify tumor areas and calculate the minimum distance between the tumor and the surgical excision margin. The system is targeted at oncology surgeons, radiologists, and oncology centers performing breast-conserving surgery, and is positioned as the first commercial software dedicated to intraoperative breast cancer diagnosis from radiographic imaging.

The underlying technology is a proprietary computer-vision and machine-learning pipeline trained on a labeled corpus of more than 100,000 breast tissue images, with annotations produced by clinicians and rechecked by radiology experts. TYRION integrates with hospital information systems (HIS) and PACS, and is offered alongside staff training, technical support, and software updates. CSB's go-to-market is enterprise field sales to oncology centers and cancer hospitals, supplemented by participation in medical conferences (e.g., the VII Breast Cancer Conference in Poznań, "Get Ahead of Cancer") and a multilingual website covering Polish, English, French, German, Italian, Czech, and Slovak. The company reports cooperation with 17 oncology centers in Poland and a technology partnership with KUBTEC, the manufacturer of the only commercially available 3D intraoperative imaging hardware.

Revenue mechanics combine a recurring TYRION software license with professional services (staff training) and ongoing technical support, packaged in customized multi-year enterprise contracts. To date, the only confirmed paying deployment is at Opolskie Centrum Onkologii (Opole Oncology Center), commencing March 2024; other relationships with the 17 Polish centers and Vitkovice (Czech Republic) are described as cooperation and sales discussions rather than confirmed commercial contracts. Capital formation has so far relied on a 2021 EU grant of 954,864.50 PLN under the Eastern Poland Operational Program 2014–2020 (total project value 1,204,318.50 PLN); no equity funding rounds, acquisitions, regulatory clearances, patents, or awards are disclosed in the available data.

Name

Centrum Systemów Bio-Medycznych sp. z o. o.

Legal name

Centrum Systemów Bio-Medycznych Sp. z o.o.

Website

https://tyrion.com.pl

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Centrum Systemów Bio-Medycznych sp. z o. o. (CSB) develops TYRION, an AI-powered medical imaging system that supports intraoperative breast cancer diagnosis from X-ray and 3D tomosynthesis images. It sells licensed software, training, and support to oncology centers and hospitals in Poland, with expansion activity in the Czech Republic and Slovakia.

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Computer Systems Design Services (541512)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Medical imaging software
• AI diagnostics
• Breast cancer detection
• Intraoperative imaging
• Radiology software

Headquarters

HQ city

Głogów Małopolski

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. TYRION AI System License: Licensing of AI software for analysis of X-ray images to healthcare facilities. Pricing is competitive and customized to individual needs and implementation scope.
2. Staff Training Services: Training programs for radiologists and technicians enabling effective use of AI image analysis systems.
3. Technical Support and Updates: Continuous technical support and regular software updates included in the service offering.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

CSB develops and licenses TYRION, an AI-powered medical diagnostic software that analyzes intraoperative X-ray images and 3D tomosynthesis scans to identify tumor tissue and calculate resection margins during breast cancer surgery. The system integrates with hospital HIS and PACS infrastructure and is sold to oncology centers and hospitals with bundled staff training and ongoing technical support.

Product overview

CSB offers a single unified product called TYRION - an AI-powered medical diagnostic software system. TYRION is designed specifically for intraoperative breast cancer diagnosis, analyzing X-ray images and 3D tomosynthesis to identify tumor tissue and calculate excision margins. The company also developed a proprietary ML-based application for annotating X-ray images. CSB positions itself as a technological leader in medical diagnostic software, with TYRION being their flagship product, developed with EU funding support (Project POPW.01.01.02-18-0056/21-00, value 1,204,318.50 PLN).

Differentiator

Problem solved

Functional benefit

Products and services

• TYRION AI-powered medical diagnostic software system that supports intraoperative breast cancer diagnosis by analyzing X-ray images and 3D tomosynthesis images to identify tumor tissue and calculate resection margins. It is the first software on the market for intraoperative breast cancer diagnosis using radiographic imaging, sold to oncology centers and hospitals with staff training and ongoing technical support.

Quantifiable outcome

• Reduces number of reoperations by providing precise intraoperative margin assessment
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• KUBTECcoreTechnology or IntegrationKUBTEC is the manufacturer of devices for intraoperative imaging and is the only company in the world producing 3D intraoperative imaging devices. CSB has partnered with KUBTEC to integrate the TYRION AI system with these devices for comprehensive intraoperative breast cancer diagnosis support.
• 17 Oncology Centers in PolandcoreStrategic or Co-development PartnerCSB cooperates with 17 oncology centers across Poland for clinical validation, data collection, and ongoing development of the TYRION system. These partnerships provide real clinical environment data essential for algorithm training.
• VitkoviceminorChannel Partner/ Reseller/ DistributorVitkovice invited CSB to present the TYRION system to participants interested in implementing Tyrion in hospitals in the Czech Republic. This led to further cooperation talks for market expansion.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• DeepHealth (RadNet): DeepHealth, a RadNet subsidiary, offers Saige-Dx, an FDA-cleared AI for breast cancer detection in mammography. It is comparable to CSB as a direct breast AI competitor with regulatory clearance and significant commercial scale, though focused on the screening use case.
• iCAD: iCAD's ProFound AI is a leading breast cancer detection AI used in mammography and tomosynthesis workflows. It is comparable to CSB as a direct competitor in AI-driven breast cancer imaging analysis for clinical decision support.
• Kheiron Medical Technologies: Kheiron Medical develops Mia, an AI breast cancer screening tool. It is comparable to CSB because both target breast cancer detection using deep learning on X-ray/mammography images, although Kheiron's primary focus is on screening workflows rather than intraoperative diagnosis.
• Therapixel: Therapixel's MammoScreen 2.0 is an AI tool for breast cancer screening on mammography and tomosynthesis. It is comparable to CSB as a peer applying deep learning to breast imaging for cancer detection, though it focuses on screening rather than intraoperative workflows.
• ScreenPoint Medical: ScreenPoint Medical offers Transpara, an AI decision-support tool for breast imaging including 3D tomosynthesis, used by radiologists to detect cancer. It is comparable to CSB because both apply machine learning to 3D breast tomosynthesis to identify suspicious tissue, although ScreenPoint addresses the screening/read workflow rather than intraoperative analysis.
• Lunit: Lunit is a Korean medical AI company with Lunit INSIGHT MMG, an AI solution for mammography that detects breast cancer. It is directly comparable to CSB because it applies deep learning to breast imaging for cancer detection, although Lunit focuses on screening rather than intraoperative analysis.
• Volpara Health Technologies: Volpara develops AI software for breast imaging, including density assessment and cancer detection analytics. It is comparable to CSB as a breast-imaging AI software vendor selling to hospitals and radiology workflows, though its product is oriented around mammography screening rather than intraoperative margin analysis.

Broad incumbents

• Hologic: Hologic is a major breast health company that manufactures 3D mammography systems and offers Genius AI for breast cancer detection. It is comparable to CSB as a broad incumbent in the breast imaging ecosystem with overlapping AI capabilities and established hospital relationships across Europe and globally.
• GE HealthCare: GE HealthCare manufactures mammography and tomosynthesis systems (e.g., Pristina) and offers AI-enabled breast imaging workflows integrated with its modality hardware. It is comparable to CSB as a broad incumbent in breast imaging that competes for the same hospital IT/AI budget.

Emerging players

• Densitas: Densitas provides AI solutions for breast density assessment and mammography quality on standard mammography equipment. It is comparable to CSB as an emerging AI breast imaging vendor targeting hospital and imaging-center workflows, though focused on density and quality metrics rather than cancer detection or intraoperative support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/centrum-system%C3%B3w-bio-medycznych-sp-z-o-o

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centrum Systemów Bio-Medycznych sp. z o. o.